Connect
MJA
MJA

Pharmaceutical preparations

Research letter

Medication delivery and dispensing interval preferences of people who use antihypertensive medications in Australia: a survey study

Carissa Bonner, Michael A Fajardo, Rachael M Keast, Emily Atkins, Niamh Chapman, Kristie R Weir, Anthony Rodgers and Aletta E Schutte

Med J Aust 2025; 223 (8): 423-425 Free

Letter to the editor

Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021

Aaron E Boyce, Tony Caccetta, Jo‐Ann See and Rosemary L Nixon AM

Med J Aust 2025; 223 (8): 439-439 Free

Letter to the editor

Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021

Michelle KY Chen, Adrian Lim and Deshan F Sebaratnam

Med J Aust 2025; 223 (8): 440-440 Free

Letter to the editor

The role of GLP‐1 receptor agonists in the management of obesity: risks and opportunities for the Australian health care system

Patrick GM Bolton

Med J Aust 2025; 223 (7): 379-379 Free

Research

Incidence of GLP‐1 receptor agonist use by women of reproductive age attending general practices in Australia, 2011–2022: a retrospective open cohort study

Kailash Thapaliya, Arianne Sweeting, Kirsten I Black, Amanda Poprzeczny, Danielle Mazza and Luke E Grzeskowiak

Med J Aust 2025; 223 (7): 365-371 Free

Research letter

Estimated carbon emissions for PBS‐subsidised prescription respiratory inhalers, Australia, 2019–2023: a descriptive analysis

Luise Kazda, Alexandra L Barratt, Sean Docking, Kristen Pickles, Darlene Cox, Ross S Bailie, Kate Wylie and Katy JL Bell

Med J Aust 2025; 223 (4): 214-217 Free

Medical education / Lessons from practice

Severe hypoglycaemia secondary to chronic opioid‐induced hypothalamic–pituitary–adrenal axis suppression: an under‐recognised phenomenon

Michael Do, Annabelle G Hayes and Malgorzata M Brzozowska

Med J Aust 2025; 222 (9): 434-435 Free

Perspective

Antidepressant prescribing in Australian primary care: time to reevaluate

Katharine A Wallis, Anna King and Joanna Moncrieff

Med J Aust 2025; 222 (9): 430-432 Free

Research

The relative toxicity of medicines detected after poisoning suicide deaths in Australia, 2013–19: a data linkage case series study

Jessy Lim, Nicholas A Buckley, Kate Chitty, Andrea L Schaffer, Jennifer Schumann, Zein Ali and Rose Cairns

Med J Aust 2025; 222 (7): 339-347 Free

Editorial

Strong medication overdose data, but we need to consider both toxicity and therapeutic need when prescribing

Angela L Chiew and Geoffrey K Isbister

Med J Aust 2025; 222 (7): 337-338 Free

Editorial

Pills, profits, and pollution: accountability for pharmaceuticals‐related greenhouse gas emissions

Angie Bone and Nick Watts

Med J Aust 2025; 222 (6): 303-304 Free

Perspective

Shortages of benzathine benzylpenicillin G in Australia highlight the need for new sovereign manufacturing capability

Rosemary Wyber, Glenn Pearson and Laurens Manning

Med J Aust 2025; 222 (5): 223-225 Free

Perspective

The role of GLP‐1 receptor agonists in the management of obesity: risks and opportunities for the Australian health care system

Christopher Kanellis, Kyle Williams, Darcy Q Holt, Jennifer Wong, Rachel David, Ravi Carothers and Suong Le

Med J Aust 2025; 222 (3): 118-121 Free

Research letter

Cannabis poisonings in Australia following the legalisation of medicinal cannabis, 2014–24: analysis of NSW Poisons Information Centre data

Rose Cairns, Sara Allaf and Nicholas A Buckley

Med J Aust 2025; 222 (3): 155-157 Free

Position statement

Updated recommendations for warfarin reversal in the setting of four‐factor prothrombin complex concentrate

Danielle Robinson, James McFadyen, Eileen Merriman, Chee Wee Tan, Ross Baker and Huyen Tran

Med J Aust 2025; 222 (1): 49-51 Free

Research

The cost of treating hypertension in Australia, 2012–22: an economic analysis

Emily R Atkins, Long Huy Nguyen, Mary Lou Chatterton, Markus Schlaich, Aletta E Schutte and Anthony Rodgers

Med J Aust 2024; 221 (11): 612-616 Free

Editorial

Cerebral palsy in Australia: optimism and challenges

Rod W Hunt

Med J Aust 2024; 221 (10): 529-530 Free

Ethics and law

Aligning legislation with clinical practice: off‐label prescribing under the microscope

Narcyz Ghinea

Med J Aust 2024; 221 (8): 417-419 Free

Research

Concurrent use of hormonal long‐acting reversible contraception by women of reproductive age dispensed teratogenic medications, Australia, 2013–2021: a retrospective cohort study

Luke E Grzeskowiak, Vivienne Moore, Kelly Hall, Jenni Ilomäki, Danielle Schoenaker, Elizabeth Lovegrove, Danielle Mazza, Kirsten I Black, Debra S Kennedy, Michael J Davies and Alice Rumbold

Med J Aust 2024; 221 (7): 367-373 Free

Perspective

Cost barriers to medication access in Australia: an analysis of the Patient Experience Survey in context

Narcyz Ghinea

Med J Aust 2024; 221 (8): 414-416 Free

Perspective

Pharmaceuticals in pregnancy: a multifaceted challenge in Australia

Stefan C Kane, Renuka Shanmugalingam and Amanda Henry

Med J Aust 2024; 221 (7): 357-359 Free

Perspective

Calling time on the use of modified‐release opioids for acute pain

Pamela E Macintyre, Melissa A Jamcotchian and Jennifer A Stevens

Med J Aust 2024; 221 (6): 293-296 Free

Medical education / Lessons from practice

Smouldering COVID‐19 XBB.1.5. subvariant pneumonitis: a case report

Sara Davison, Tanmay Kanitkar, Dimitrios Menouhos, Thomas Ewin, Catherine S Marshall, Peter Boan and Sonja Janson

Med J Aust 2024; 221 (5): 244-245 Free

Letter to the editor

Hidden danger: maize starch excipient allergy

Wala Hamid Haj Ali, Corey Borg and Catherine Leggett

Med J Aust 2024; 221 (5): 285-286 Free

Medical education / Key research skills

Understanding modelled economic evaluations: a reader's guide for clinicians

Winnie Chen, Martin Howell, Alan Cass, Gillian Gorham and Kirsten Howard

Med J Aust 2024; 221 (6): 302-307 Free